Overview

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
Study on the registration of coronary heart disease patients undergoing PCI in Chinese's population. Get the incidence of adverse events in these patients after PCI, a clear type of adverse reaction, forms, influencing factors, to establish risk management processes, clinical safety and reasonable treatment, and provide the basis for further research and reference.
Details
Lead Sponsor:
The Third Xiangya Hospital of Central South University
Treatments:
Clopidogrel
Platelet Aggregation Inhibitors
Ticagrelor